Cronos Group Inc vs Keel Infrastructure Corp. Common Stock — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Keel Infrastructure Corp. Common Stock trades at $3.04 (market cap $1.93B). The key difference: Keel Infrastructure Corp. Common Stock is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Keel Infrastructure Corp. Common Stock for 1 Days on average.
| CRON | KEEL | |
|---|---|---|
Market Cap | $1.18B | $1.93B |
Volume | 968,037 | 30,868,523 |
Sector | Health | Technology |
52-Week High | $3.55 | $6.66 |
52-Week Low | $2.30 | $1.71 |
Typical Hold Time | 22 Days | 1 Days |
Enterprise Value | $387.62M | $2.25B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 results, beating earnings estimates with 58% YoY revenue growth, and maintains a robust balance sheet with $827 million in cash and no debt. Recent investor day highlighted expansion in Canada and international markets.
Outlook is mixed; profitability improved with net income margin turning positive in 2026 forecasts, but high EV/EBITDA of 43 suggests premium valuation. Risks include execution of growth plans and cannabis sector volatility. Analyst consensus is cautious with 60% hold ratings.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →